Video Library

This presentation reviews some of the short- and long-term cardiovascular toxicities that can develop after stem cell transplantation. It describes strategies that patients and their physicians can use to reduce the risk of developing cardiovascular problems after transplant.

Several types of infection can occur after a stem cell or bone marrow transplant and can complicate recovery for patients. This presentation describes the infection risks during the posttransplant period, therapies to treat them, and some measures to prevent them.

Distintos tipos de infecciones pueden ocurrir después de un trasplante y pueden complicar la recuperación de los pacientes. Esta presentación describe los riesgos de infecciones después de un trasplante, las terapias para tratarlas, y algunas medidas para prevenirlas.

Graft-versus-host-disease (GVHD) is a common challenge for patients who undergo a stem cell transplant using cells from a donor (an allogeneic transplant). It can be mild, moderate or severe. This presentation reviews the types of GVHD, the organs most often affected, common symptoms, and traditional as well as newer therapies for treating GVHD.

La Enfermedad de Injerto contra Huésped (EICH) puede ser aguda o crónica. Este taller explica la diferencia entre ambas, los factores de riesgo, su incidencia, cuáles son los síntomas, cuándo comienzan y cuánto duran. También explica las terapias para el tratamiento de la EICH aguda y crónica, así como los efectos secundarios de esos medicamentos.

Several new therapies have recently been approved to prevent and treat graft-versus-host disease (GVHD) and more are being studied. The new therapies are more effective than the standard GVHD therapies and should result in a lower incidence of GVHD with fewer toxicities for patients, going forward.

Este video informa acerca de los avances en la prevención y el tratamiento de la enfermedad de injerto contra huésped aguda y crónica, así como sobre las drogas que han sido aprobadas por el FDA y algunos ensayos clínicos que se están desarrollando actualmente.

Living with graft-versus-host disease (GVHD) can be challenging not only for the patient, but for the patient’s caregiver as well. It is vital for family caregivers to maintain their own health and quality of life while caring for the patient/loved-one. This presentation presents a road map for how to do just that.

Graft-versus-host disease (GVHD) is a condition that can occur after a stem cell using donor cells (an allogenic transplant). This presentation describes how GVHD can affect the mouth, esophagus, stomach, small intestine, large intestine and liver.

Graft-versus-host disease (GVHD) is a common complication after a stem cell transplant with donor cells (allogeneic transplant). This presentation discusses the manifestations of chronic GVHD on the skin, hair, and nails; how skin GVHD can affect activities of daily living; and pharmacologic and non-pharmacological therapies that can help patients who have skin GVHD

The eyes are one of the most common sites for graft-versus-host-disease following stem cell transplantation. This presentation describes the most typical forms of ocular GVHD and the wide array of remedies to effectively treat symptoms of this problem. (Note: In this presentation, when the speaker uses the term bone marrow transplants, it includes stem cell and cord blood transplants as well.)

Dry mouth, mouth sores and reduced saliva production are common after a stem cell transplant. Being vigilant about daily mouth care and finding a dentist who is familiar with problems that can arise after transplant are important steps to take to protect your mouth long-term after transplant.